These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 38343494)
61. Low prevalence of obstructive lung disease in a suburban population of Malaysia: A BOLD collaborative study. Loh LC; Rashid A; Sholehah S; Gnatiuc L; Patel JH; Burney P Respirology; 2016 Aug; 21(6):1055-61. PubMed ID: 27061596 [TBL] [Abstract][Full Text] [Related]
62. Chronic airflow limitation and its relation to respiratory symptoms among ever-smokers and never-smokers: a cross-sectional study. Toren K; Schiöler L; Lindberg A; Andersson A; Behndig AF; Bergström G; Blomberg A; Caidahl K; Engvall J; Eriksson M; Hamrefors V; Janson C; Kylhammar D; Lindberg E; Lindén A; Malinovschi A; Persson HL; Sandelin M; Eriksson Ström J; Tanash HA; Vikgren J; Östgren CJ; Wollmer P; Sköld CM BMJ Open Respir Res; 2020 Aug; 7(1):. PubMed ID: 32759170 [TBL] [Abstract][Full Text] [Related]
63. Burden of obstructive lung disease in a rural setting in the Philippines. Idolor LF; DE Guia TS; Francisco NA; Roa CC; Ayuyao FG; Tady CZ; Tan DT; Banal-Yang S; Balanag VM; Reyes MT; Dantes RB Respirology; 2011 Oct; 16(7):1111-8. PubMed ID: 21801277 [TBL] [Abstract][Full Text] [Related]
64. The analyses of risk factors for COPD in the Li ethnic group in Hainan, People's Republic of China. Ding Y; Xu J; Yao J; Chen Y; He P; Ouyang Y; Niu H; Tian Z; Sun P Int J Chron Obstruct Pulmon Dis; 2015; 10():2593-600. PubMed ID: 26664107 [TBL] [Abstract][Full Text] [Related]
65. Prevalence of Airflow Obstruction as Measured by Spirometry, in Rural Southern Indian Adults. Christopher DJ; Oommen AM; George K; Shankar D; Agrawal A; Thangakunam B COPD; 2020 Apr; 17(2):128-135. PubMed ID: 32020813 [TBL] [Abstract][Full Text] [Related]
66. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
67. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study. Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024 [TBL] [Abstract][Full Text] [Related]
68. Control of chronic obstructive pulmonary disease in urban populations: findings from a cross-sectional prevalence survey in Shenzhen, China. Ji LC; Yin JF; Lu CR; Guan HY; Tan WG; Wang LW; Jiang Q Environ Sci Pollut Res Int; 2022 Feb; 29(8):11843-11853. PubMed ID: 34553282 [TBL] [Abstract][Full Text] [Related]
69. Asthma-COPD overlap syndrome (ACOS) in primary care of four Latin America countries: the PUMA study. Montes de Oca M; Victorina Lopez Varela M; Laucho-Contreras ME; Casas A; Schiavi E; Mora JC BMC Pulm Med; 2017 Apr; 17(1):69. PubMed ID: 28431499 [TBL] [Abstract][Full Text] [Related]
70. The Risk Factors and Characteristics of COPD Among Nonsmokers in Korea: An Analysis of KNHANES IV and V. Lee SH; Hwang ED; Lim JE; Moon S; Kang YA; Jung JY; Park MS; Kim SK; Chang J; Kim YS; Kim SY Lung; 2016 Jun; 194(3):353-61. PubMed ID: 27038474 [TBL] [Abstract][Full Text] [Related]
71. Prevalence and Associated Factors of Chronic Obstructive Pulmonary Disease Among Adults in Neno District, Malawi: A Cross-Sectional Analytical Study [Letter]. Fikri E Int J Chron Obstruct Pulmon Dis; 2024; 19():665-666. PubMed ID: 38476121 [No Abstract] [Full Text] [Related]
72. Lung function reductions associated with motor vehicle density in chronic obstructive pulmonary disease: a cross-sectional study. Nitschke M; Appleton SL; Li Q; Tucker GR; Shah P; Bi P; Pisaniello DL; Adams RJ Respir Res; 2016 Oct; 17(1):138. PubMed ID: 27776510 [TBL] [Abstract][Full Text] [Related]
73. Prevalence and risk factors of chronic obstructive pulmonary disease in Anhui Province, China: a population-based survey. Zha Z; Leng R; Xu W; Bao H; Chen Y; Fang L; Liu Z; Ye D BMC Pulm Med; 2019 May; 19(1):102. PubMed ID: 31142295 [TBL] [Abstract][Full Text] [Related]
74. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Liu S; Zhou Y; Liu S; Chen X; Zou W; Zhao D; Li X; Pu J; Huang L; Chen J; Li B; Liu S; Ran P Thorax; 2017 Sep; 72(9):788-795. PubMed ID: 27941160 [TBL] [Abstract][Full Text] [Related]
75. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study. Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926 [TBL] [Abstract][Full Text] [Related]
76. Early chronic obstructive pulmonary disease: Associations of two spirometry criteria with clinical features. Mochizuki F; Tanabe N; Iijima H; Shimada T; Shiraishi Y; Maetani T; Yamazaki H; Shimizu K; Suzuki M; Chubachi S; Ishikawa H; Naito T; Masuko H; Sakamoto T; Masuda I; Sato S; Hizawa N; Hirai T Respir Med; 2022; 204():107011. PubMed ID: 36270155 [TBL] [Abstract][Full Text] [Related]
77. Prevalence and determinants of chronic obstructive pulmonary disease in HIV infected patients in an African country with low level of tobacco smoking. Pefura-Yone EW; Fodjeu G; Kengne AP; Roche N; Kuaban C Respir Med; 2015 Feb; 109(2):247-54. PubMed ID: 25538018 [TBL] [Abstract][Full Text] [Related]
78. High prevalence of obstructive lung disease in non-smoking farmers: The Irish farmers lung health study. Cushen B; Sulaiman I; Donoghue N; Langan D; Cahill T; Nic Dhonncha E; Healy O; Keegan F; Browne M; O'Regan A Respir Med; 2016 Jun; 115():13-9. PubMed ID: 27215498 [TBL] [Abstract][Full Text] [Related]
79. Prevalence of chronic obstructive pulmonary disease in Zonguldak province of Turkey. Örnek T; Tor M; Kıran S; Atalay F Tuberk Toraks; 2015 Sep; 63(3):170-7. PubMed ID: 26523898 [TBL] [Abstract][Full Text] [Related]
80. Pulmonary function in an international sample of HIV-positive, treatment-naïve adults with CD4 counts > 500 cells/μL: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. Kunisaki KM; Niewoehner DE; Collins G; Nixon DE; Tedaldi E; Akolo C; Kityo C; Klinker H; La Rosa A; Connett JE; HIV Med; 2015 Apr; 16 Suppl 1(0 0):119-28. PubMed ID: 25711330 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]